Key Takeaways
- Mixed quarter, regulatory overhang: Bajaj General’s underwriting loss widened on NATCAT claims while Bajaj Life delivered a 40% VNB jump; the IRDAI distribution consultation paper injects uncertainty across both insurers.
- Life insurance is the margin story: VNB margin expanded 4.5% YoY to 21.6%, driven by a deliberate mix shift toward protection and annuity, though management warns this pace of expansion is not sustainable.
- General insurance profitability hit: Combined ratio rose to 104.5% as NATCAT claims of ₹75 crores net and lower capital gains dragged PAT down to ₹420 crores from ₹517 crores YoY.
- Bajaj Finance raises growth capital: Board approved a ₹17,500 crore capital raise via QIP and preferential warrants to Bajaj Finserv, signaling confidence in the lending cycle ahead.
- What to watch next quarter: Whether the IRDAI distribution paper crystallizes into draft regulations, the pace of Bajaj Life’s agency-led protection push, and Bajaj Finance’s opex ratio improvement from AI implementation.
General Insurance: NATCAT Hit and Regulatory Uncertainty
- Growth dragged by tender business: GWP grew 10%, below the industry’s 12%, because tender-driven crop and government health business weighed on the headline; excluding these, GWP grew 21% vs industry 13%, led by health at 31% and motor at 18%.
- Underwriting loss widened: Underwriting loss rose to ₹115 crores from ₹92 crores YoY, largely from NATCAT claims of ₹75 crores net during the quarter; combined ratio excluding NATCAT was ~102%, and excluding both NATCAT and a temporary 1/n regulation impact it was 101.4%.
- PAT decline driven by multiple headwinds: PAT fell to ₹420 crores from ₹517 crores YoY because of lower capital gains from volatile equity markets, the NATCAT claims, and a ~₹50 crore impact from capital reduction via buyback and dividend in the last six months.
- Motor growth tactical, not structural: Motor grew 14–15%, better than industry, with sourcing decisions made weekly based on a RORAC model across 4-wheeler, 2-wheeler and CV segments; tactical changes are made as pockets of positive outcome emerge.
- Health claims ratio rise is mix-driven: The increase came from a higher proportion of tender-driven government business in the NEP mix, not from underlying segmental deterioration; Q2 also carries observed monsoon seasonality across retail, employer-employee and government lines.
- NATCAT risk contained historically: Management noted that every 2–3 years could see a larger NATCAT trend, but the maximum net hit in the last 10 years has not crossed close to ₹100 crores.
- Motor retention decision deferred: Retention limits are reviewed annually; a strategic decision will be made at year-end, with no real need to change limits at this stage.
Singhel: "If you are a distributor, now, in any reforms, would you want your business or customer base to go down? I say no, because it serves a purpose. I think the big thing that the regulator is looking at is to get mis-selling down. And the GI business, the mis-selling is very low if you look at it."
Life Insurance: VNB Surge and the Protection Pivot
- VNB growth the standout metric: VNB grew 40% to ₹512 crores, with NBM expanding 4.5% to 21.6%; the rolling 12-month NBM crossed 20% to 20.8% despite GST impact, driven by the revamped Bajaj Life 2.0 strategy focused on sustainable and profitable growth.
- Retail premium growth muted by mix: Retail weighted received premium grew only 5%, milder than industry, because of a continued increase in term mix (~3.4% up) which carries a lower ticket size.
- Protection is the engine: Retail protection contributed 11% of overall retail business, growing 51% YoY; group protection grew 81%; agency protection sold grew 54% YoY as the company deliberately focused on getting the product mix right.
- Agency growth sacrificed for quality: Agency growth looks slow because the company prioritized streamlining the protection mix; management may follow this route for another quarter before feeling comfortable that it is on a self-sustaining path.
- Non-par to annuity shift holding: The mix shifted from ~18% non-par / 5% annuity in Q1 last year to ~13% non-par / ~10% annuity within two quarters, and that mix has held for almost a year; the shift began when pricing intensity in non-par was observed and opportunity in annuity emerged.
- Persistency dips in line with industry: Some persistency dips are visible over certain cohorts; the 13th-month dip partly stems from non-par products sold earlier, while the 25th-month dip of ~4% is largely because markets have not performed well and some policyholders are timing the market, though large-ticket policyholders tend to return.
- PAT growth on a low base: PAT rose to ₹55 crores from ₹13 crores YoY, with growth amplified because last year carried a one-time GST impact of ₹112 crores, partially offset by lower capital gains from the external macro environment.
- New distribution channels building: Operations commenced in GIFT City in October; the retail business with IndusInd Bank is expected to start from Q3, with pickup from Q4 FY27; tie-ups with Yes Bank, AU Bank and Federal Bank were completed in the last 18 months.
Sreenivasan: "If I were to take a parallel with an ordinary business which is not insurance, this would be the equivalent of earnings growth and what you people would call compounding. ... Our quest for the management and for us has always been to continue to grow value of new business faster than our top line growth."
IRDAI Distribution Reforms: The Overhang
- Consultation paper is early-stage: The IRDAI paper on recalibrating economics of insurance distribution has been published; both insurance companies are providing feedback, but management stressed it is premature to draw conclusions since draft regulations and final regulations are still to follow.
- Short-term pain, medium-term gain expected: Management acknowledged that any large-scale initiative improving the customer proposition may lead to short-term impact for insurers and distributors, but the sector historically bounces back stronger in the medium to long term.
- GI credit attachment business at risk: While some impact is expected on credit attachment business, management does not expect a very large impact because BAGIC is not the top player in that segment; however, 80%+ of lives written on health and protection are done through group products, and a significant commission reduction could have serious repercussions on overall business penetration.
- Life insurance EOM math manageable: If proposed commissions come as drafted, ~9% of GWP expense ratio would be knocked off from FY2026 levels over a 3-year walk to FY2029 end; management feels comfortable because volumes could increase if the customer proposition improves, and three years of renewals coming in at low cost provide a mathematical cushion.
- Motor TP commissions structurally different: Business volume in the market does not change if commission changes because motor insurance is mandatory by law; what changed historically was the distribution method.
Sahni: "As this is a consultation paper at this stage, it would be followed by draft regulations for comments and then the final regulations shall be issued. Hence, in that sense, it would be premature to come to any conclusion basis this consultation paper."
Bajaj Finance: Capital Raise and Efficiency Promise
- Capital raise signals growth intent: The Board approved a ₹11,700 crore QIP and ₹5,800 crore preferential issue of warrants to Bajaj Finserv on 1 October 2026, positioning the franchise for the next leg of lending growth.
- Opex ratio flat but AI promise ahead: Opex to NTI was flat at 33%, but management expressed confidence in improving the ratio by 25–40 bps in FY2027 due to AI implementation, citing visibility of green shoots in operating efficiencies.
- Loan losses stable with a prudent buffer: Loan losses and provisions stood at ₹2,166 crores vs ₹2,080 crores YoY; Q2 includes a prudent management and macroeconomic provision of close to ₹340 crores; the loan losses to AUF ratio declined to 1.56% vs 1.88% YoY.
Emerging Businesses: Path to Breakeven
- BHFL delivered steady growth: PAT grew 18% to ₹757 crores on higher variable fee income, operating efficiencies on opex and lower credit cost; AUM surpassed the ₹1.5 lakh crore milestone.
- Bajaj Markets back on growth track: Revenue grew 45% to ₹120 crores after planned digital customer journey enhancements which had impacted growth last year; some revenue structures are now trail-based, providing stability, predictability and non-linearity; the company is on track to hit its planned quarterly breakeven target in Q4 FY27.
- Bajaj Finserv Direct nearing breakeven: Expected to break even in Q4 FY27 on a quarterly basis and full-year FY28; will expand beyond lending marketplace into insurance and then investment marketplace; no need for capital going forward, though marketplace expansion may need some capital but not material.
- Bajaj Health revenue degrew: Revenue registered degrowth because of restructuring required in some partnerships attributable to RBI’s revised circular on business conduct by NBFCs; H2 outlook is wait-and-watch given the RBI circular impact and proposed distribution reforms.
- AMC crossed a milestone: AUM crossed ₹40,000 crores before closing at ~₹35,760 crores, 24% growth YoY; will need another ₹300 crores till breakeven, probably FY2029, at an AUM of ₹90,000–₹1 lakh crore.
- ALT business commenced: Launched PMS business and achieved first close of a real estate AIF this quarter.
- Reinsurance venture progressing: In the process of filing for necessary approvals with IRDAI; will need ~₹500 crores over the next 2–3 years.
- Total capital needs manageable: Less than ₹2,000 crores required for all emerging businesses in the next 18 months; current surplus of ~₹4,700 crores plus dividends from material subsidiaries is sufficient to fund investments.
Health Insurance Economics and Regulatory Tailwinds
- Hospital cost inflation the real problem: Management argued that hospital inflation exceeds average country inflation, and if unaddressed, healthcare will become unaffordable; government steps to bring hospital payments to a reasonable standard will help bring down claims costs and end-consumer pricing of health insurance premiums.
- GST removal a positive signal: The government has removed GST on health insurance premiums following industry representation, a tailwind for affordability and penetration.
- Tender-driven health loss ratio to improve: The health loss ratio is expected to come down because the tender business is structured as two-plus-one years, providing visibility on normalization.
Singhel: "If you want the health insurance premium to be at a reasonable level, you have to address the biggest component. ... The hospital inflation is more than the average inflation of the country, that is going to lead to a scenario where the healthcare will become unaffordable for the user."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Bajaj Finance opex ratio improvement | Improve opex to NTI ratio by 25–40 bps via AI implementation | FY2027 |
| Bajaj Markets quarterly breakeven | Hit planned quarterly breakeven target | Q4 FY27 |
| Bajaj Finserv Direct quarterly breakeven | Break even on quarterly basis; full-year breakeven in FY28 | Q4 FY27 / FY28 |
| Bajaj Health full-year breakeven | Full-year break-even targeted; quarterly break-even attempt in Q4 FY28 | Year after next / Q4 FY28 |
| AMC breakeven | Break-even at ₹90,000–₹1 lakh crore AUM; needs ~₹300 crores more | Probably FY2029 |
| Ind AS and RBC implementation | Both expected by 1st April; no indication of pushback | 1 April 2027 |
| Life insurance EOM compliance | ~9% of GWP expense ratio knocked off from FY2026 levels over 3-year walk if proposed commissions come as drafted | By FY2029 end |
| IndusInd Bank channel contribution | Pickup expected; should make up significant part of institutional business growth | From Q4 FY27 |
| Bajaj Life agency protection focus | May continue current protection-mix focus for another quarter before assessing sustainability | Another quarter |
Key Metrics
| Metric | Q2 FY27 |
|---|---|
| Consolidated total income | ₹43,416 cr, +17% YoY |
| Consolidated profit after tax | ₹5,952 cr, +25% YoY |
| Consolidated PAT attributable to owners | ₹2,758 cr, +23% YoY |
| Bajaj General Insurance GWP | ₹7,056 cr, +10% YoY; excluding tender-driven crop and govt health, +21% |
| Bajaj General Insurance combined ratio | 104.5%, vs 102.3% YoY; 101.4% excluding NATCAT and 1/n regulation impact |
| Bajaj General Insurance PAT | ₹420 cr, vs ₹517 cr YoY; impacted by NATCAT claims of ₹75 cr net and capital reduction impact of ~₹50 cr |
| Bajaj General Insurance annualized ROE | 16.2%, at 200% solvency |
| Bajaj General Insurance solvency | ~230% |
| Bajaj Life Insurance retail weighted received premium | ₹1,942 cr, +5% YoY |
| Bajaj Life Insurance VNB | ₹512 cr, +40% YoY |
| Bajaj Life Insurance NBM | 21.6%, vs 17.1% YoY; rolling 12-month NBM at 20.8% |
| Bajaj Life Insurance PAT | ₹55 cr, vs ₹13 cr YoY; last year included one-time GST impact of ₹112 cr |
| Bajaj Life Insurance solvency | 255% |
| Bajaj Finance AUM | ~₹584,000 cr, +26% YoY |
| Bajaj Finance PAT | ~₹6,367 cr, +29% YoY |
| Bajaj Finance gross NPA / net NPA | 1.06% / 0.42%, vs 1.88% loan losses to AUF ratio YoY |
| Bajaj Housing Finance AUM | ₹1.5 lakh cr+, +25% YoY |
| Bajaj Housing Finance PAT | ₹757 cr, +18% YoY |
| Bajaj Housing Finance gross NPA / net NPA | 29 bps / 12 bps |
| Bajaj Markets operating revenue | ₹120 cr, +45% YoY |
| Bajaj AMC AUM | ~₹35,760 cr, +24% YoY; crossed ₹40,000 cr milestone intra-quarter |
| Bajaj AMC equity mix | 60% of AUM; non-group share at ~91% |
| Bajaj Life retail protection growth | +51% YoY; contributed 11% of overall retail business |
| Bajaj Life group protection growth | +81% YoY |
| Bajaj Life agency protection growth | +54% YoY |
| Bajaj Life 25th-month persistency dip | ~4%, largely from market underperformance |
| Bajaj Finserv Health transactions | 0.57 cr healthcare transactions during the quarter |
| Bajaj Finance opex to net total income | 33%, flat YoY; expects 25–40 bps improvement in FY2027 |
| Bajaj Finance loan losses and provisions | ₹2,166 cr, vs ₹2,080 cr YoY; includes ~₹340 cr prudent management and macro provision |
| Bajaj Housing Finance opex to net total income | 19.1%, vs 19.7% YoY |
| Bajaj General Insurance health segment growth | +31% YoY |
| Bajaj General Insurance motor segment growth | +18% YoY |
| Bajaj General Insurance underwriting loss | ₹115 cr, vs ₹92 cr YoY; includes NATCAT claims of ₹75 cr net |
| Bajaj General Insurance AUM | ₹36,313 cr, vs ₹34,974 cr YoY |
| Bajaj Life Insurance GWP growth | +23% YoY; renewal premium growth of 17% |
| Bajaj Life Insurance AUM | ₹146,322 cr, +11% YoY |
| Bajaj Life Insurance non-par product mix | 19.7%, vs 17.1% last year |
| Bajaj Finance new loans booked | 1.34 cr, +11% YoY |
| Bajaj Finance capital adequacy | 20.3% |
| Bajaj Housing Finance capital adequacy | 21.2% |
| Bajaj Markets total disbursements | ₹2,535 cr, vs ₹2,269 cr QoQ and ₹1,549 cr YoY |
| Bajaj AMC incremental SIP book growth | +42% YoY; SIP folios +41% YoY |
| Bajaj Finserv Health provider network | 1,30,000+ doctors, 32,000+ hospitals, 10,000+ lab touch points |
| Bajaj Life VNB growth for H1 FY27 | +53% |
| Bajaj Life NBM expansion in Q2 FY27 | 4.5% YoY |
| Bajaj General Insurance GWP ex-tender growth | +21%, vs industry growth of ~13% |
| Bajaj General Insurance combined ratio ex-NATCAT | ~102% |
| Bajaj General Insurance combined ratio ex-NATCAT and 1/n | 101.4% |
| Bajaj Life term mix increase | +3.4% |
| Bajaj Life rolling 12-month NBM | 20.8% |
| Bajaj Finance loan losses to AUF ratio | 1.56%, vs 1.88% YoY |
| Bajaj Housing Finance home loans growth | +22% YoY |
| Bajaj Housing Finance LAP growth | +26% YoY |
| Bajaj Housing Finance LRD growth | +39% YoY |
| Bajaj Housing Finance developer finance growth | +13% YoY |
| Bajaj Housing Finance net interest income | ₹1,055 cr, +10% YoY |
| Bajaj AMC rank by AUM | 26th among all mutual funds in India |
| Bajaj Life proprietary sales term growth | +49% YoY |
| Bajaj Life face-to-face institutional term growth | +62% YoY |
| Bajaj Life GWP expense ratio optimization | ~1% drop from cost optimization |
| Bajaj Life proposed commission cut impact on GWP expense ratio | ~8% reduction, excluding GST and stamp duty; total ~9% from FY2026 levels |
| Bajaj Finserv Direct expected quarterly breakeven | Q4 FY27 |
| Bajaj Finserv Health expected full-year breakeven | FY29 (per an analyst's math); Q4 FY28 quarterly breakeven attempt |
| Bajaj AMC expected breakeven AUM | ₹90,000 cr to ₹1 lakh cr, likely in FY2029 |
| Bajaj Finserv surplus capital | ~₹5,000 cr |
| Bajaj Finance additional capital raise approved | ₹11,700 cr via QIP and ₹5,800 cr via preferential warrants to Bajaj Finserv |
| Bajaj General Insurance buyback and dividend payout last quarter | ~₹3,500 cr |
| Bajaj General Insurance capital reduction impact on PAT | ~₹50 cr in last 6 months |
| Bajaj Life one-time GST impact last year | ₹112 cr |
| Bajaj Finance prudent management and macro provision | ~₹340 cr |
| Bajaj Finserv Health FY27 capital consumption | less than ₹200 cr |
| Bajaj AMC capital needed till breakeven | ~₹300 cr |
| Reinsurance venture capital needed | ~₹500 cr over next 2–3 years |
| ALTs business sponsor capital needed | ~₹1,100 cr in another year |
| All emerging businesses combined capital needed | less than ₹2,000 cr in next 18 months |
| Health insurance premium distribution | ~80% to hospitals, 18% GST to government, ~20% to insurers |
| Health claims cashless proportion | more than 67%; 80%+ negotiated rate |